Index
smooth muscle tumors
epithelioid, 479,
481
glomus, 479-480
leiomyoma, 478-479
leiomyosarcoma, 479,
480, 481
pericytic tumors, 479-480
SMZL (splenic marginal zone lymphoma),
32-33
soft tissue sarcomas (STS), 42
soft tissue tumors
adipocytic
see
adipocytic tumors
alveolar soft part sarcoma, 36,
489- 490
angiomatoid fibrous histiocytoma, 487
angiomyxoma, 486
chordomas, 475
clear cell sarcoma, 490
desmoplastic small round cell tumor,
490- 491
epithelioid sarcoma, 488-489
extrarenal rhabdoid, 491
fibroblamatosis, 476
fibrohistiocytic, 477-478
fine needle aspiration biopsy, 472
intramuscular myxoma, 486
mediastinum, 798-799
molecular studies, 508
morphological approach, 472
muscular, 478-482
myofibroblastoma, 476-477
myxoid lesions, 472
neoplasms w ith perivascular epithelioid
cell differentiation, 491-492
ossifying fibromyxoid tumor, 487-488
pleomorphic hyalinizing angiectatic tum or
o f soft part, 487
sarcomas, 569-570
skeletal muscle, 480-482
soft tissue carconmas, 42
subtypes, 472
superficial, image-guided FNA, 604
synovial sarcoma, 488
vascular, 482-486
solid pseudopapillary neoplasm, pancreas,
903-904
specimens, cytologic
see also
immunocytochemistry (ICC)
adequacy of, Bethesda System,
78-81
collection of, 60, 1043
cross-contamination, 72-73
double-labeling method, 1046
gastrointestinal tract, 374
immunocytochemistry,
1043-1049
inconclusive, in respiratory tract, 329
interpretation, 50
mishandling, 73
peritoneal washings, 292
processing, 50, 65, 72
radiation biology, 951-957
respiratory tract, 997-998
sensitivity and specificity of, 49
direct sampling, endometrium, 252
human papillomavirus (HPV), 153
sputum, 352-356
staining, 72-73
unsuccessfully processed, 1036-1037
urine, 411
spectral karyotype hybridization
(SKY),
15
,
28
spermatozoa, as smallest human cells, 3
spherulosis, collagenous,
726
spindle and pleomorphic lipomas, 473
spindle cell sarcomas, 476
spiral fibrils o f Erbeth, herpes infection, 109
Splendore Hoeppli effect, 101, 322
splenic marginal zone lymphoma (SMZL), 32-33
spray fixation, 978
sputum
alcohol and carbowax, prefixed w ith
(Saccomanno), 304
blastomycosis, pulmonary, 321
cytology, 54
diagnostic accuracy
correlation w ith FNA, 359-361
correlation w ith histology, 356-357
sensitivity and specificity, 352-356
dysplasia in, 329
electron microscopy, 308
fresh and unfixed, 304
induced, 304-305
prefixed, 304
pulmonary infarcts, 310
sensitivity and specificity o f specimens,
352-356
squamous cell carcinoma, 335
tracheostomy patients, 314
squames, anucleated,
139
squamocolumnar junction
ectocervix, 132
mature squamous metaplasia, 143
squamous cell carcinoma
anus, 284-285, 400-401
breast cancer, 751-752,
754
in children, 937
conjunctiva, 460
defined, 85
effusions,
516
,
552-553
esophagus, 383-384
incidence of, 48
and inflam m ation, 95
invasive, 335-337
key features, 67
lung cancer, 330-331, 334-338
malignant cells,
68
moderately differentiated,
331
,
337
pleomorphic cells,
68
poorly differentiated,
331
,
338,
384
recurrent, after radiation, 955
renal pelvis, 843
salivary glands, 622
in situ, 334-335
skin, 503-504
urinary tract tumors, 424
vagina, 282
vulva, 277
well differentiated, 336,
337
,
384
squamous cells
see also
squamous cell carcinoma
o f anus, 285
atypical, o f cervix
see
atypical squamous
cells (ASC)
o f cervix (atypical)
see
ASC-US
(atypical squamous cells of
undetermined significance)
o f lungs, 308-310
urothelium and specialized lining, 413
squamous cellularity, Bethesda System, 80
squamous epithelium, 95-96
pseudoepitheliomatous hyperplasia
of, 99
squamous intraepithelial lesions (SILs)
see also
squamous intraepithelial
neoplasia
Bethesda System, 82-83
high-grade
see
HSIL (high-grade
squamous intraepithelial lesions)
low-grade
see
LSIL (low-grade
squamous intraepithelial lesions)
management, 85
morphologic features, 84-85
two-tiered terminology, conceptual
basis, 84
and vaginal intraepithelial neoplasia, 282
squamous intraepithelial neoplasia,
cervix, 153-184
see also
squamous intraepithelial lesions
(SILs)
carcinoma
in situ
(CIS)
see
carcinoma
in situ
(CIS)
cervical intraepithelial neoplasia,
155-184
dysplasia, 154-155
mild, 160
immunocytochemistry, 197-199
Papanicolaou classification, 153-154
rate o f progression
review o f literature, 167-168
terminology, 153
squamous metaplasia
atypical, 313,
314
o f cervix, 139-144
immature, 141-143,
142, 143
mature, 143-144,
145
reserve cell hyperplasia, 140-141
o f respiratory tract, 310, 312-314
squash method, cytogenetics, 23
staining
see also
cytopreparatory techniques
automated systems, 1037
automatic T2000 and T3000
technique, 988
Congo red, 636
cytokeratin (CK)-7 stain, 813
cytoplasmic, 7
D iff-Q uik stain
see
D iff-Q uik stain
environmentally friendly staining
procedure, 988
G-band, 4
Giemsa
see
Giemsa staining;
May-Gr├╝nwald Giemsa (modified) stain
hematoxylin and eosin (H&E)
see
hematoxylin and eosin (H&E) staining
immunenzymatic
see
immunenzymatic
staining
immunohistochemical
see
immunohistochemical staining
on-site quick staining procedure, 988
periodic acid-Shiff
see
PAS (periodic
acid-Shiff) staining
Q-band, 25
quality assurance measures, 60
Romanowsky
see
Romanowsky staining
Sakura Tissue-Tek DRS Automatic Slide
Stainer, 988
silver stains
see
silver stains
1117
previous page 1100 ComprehensiveCytopathology 1104p 2008 read online next page 1102 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off